- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arcticzymes Technologies ASA (AZT)
Arcticzymes Technologies ASA stock price live, this page displays OL AZT stock exchange data. View the AZT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arcticzymes Technologies ASA real time stock price chart below.
What Is the Arcticzymes Technologies ASA Stock Price Today?
The Arcticzymes Technologies ASA stock price today is 21.90.
What Is the Stock Symbol for Arcticzymes Technologies ASA?
The stock symbol for Arcticzymes Technologies ASA is "AZT."
What Stock Exchange Does Arcticzymes Technologies ASA Trade On?
Arcticzymes Technologies ASA is listed and trades on the Oslo stock exchange.
Is Arcticzymes Technologies ASA a Good Stock to Buy?
Determining whether Arcticzymes Technologies ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZT quote. (ISIN: NO0010014632)
What Is the Arcticzymes Technologies ASA Stock Price Today?
The Arcticzymes Technologies ASA stock price today is 21.90.
What Is the Stock Symbol for Arcticzymes Technologies ASA?
The stock symbol for Arcticzymes Technologies ASA is "AZT."
What Stock Exchange Does Arcticzymes Technologies ASA Trade On?
Arcticzymes Technologies ASA is listed and trades on the Oslo stock exchange.
Is Arcticzymes Technologies ASA a Good Stock to Buy?
Determining whether Arcticzymes Technologies ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZT quote. (ISIN: NO0010014632)
Currency in NOK
21.90
+0.80(+3.79%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.60
21.90
52 wk Range
13.60
31.40
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.6021.90
52 wk Range
13.6031.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AZT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
31.50
Upside
+43.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Arcticzymes Technologies ASA Company Profile
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Arcticzymes Technologies ASA Earnings Call Summary for Q3/2025
- ArcticZymes reported 24% YoY revenue growth to NOK 28.5M in Q3 2025, but missed forecasts of NOK 31.45M, causing stock to fall 8.93% to NOK 25.50
- EBITDA improved significantly to NOK 3.5M from negative NOK 2.3M in Q3 2024, while operating expenses were reduced by NOK 2.4M year-over-year
- Despite quarterly growth, year-to-date revenue declined 2%, highlighting challenges in maintaining growth momentum with significant dependence on few large customers
- CEO Michael Akoh announced plans to explore inorganic growth opportunities while expanding partnerships with CDMOs to drive continued growth in 2026
- The company maintains a strong cash position of approximately NOK 260M and sees increasing opportunities as regulatory bodies implement stricter requirements
Last Updated: 2025-11-06, 03:50 a/m
Read Full TranscriptCompare AZT to Peers and Sector
Metrics to compare | AZT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAZTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 155.3x | −2.4x | −0.5x | |
PEG Ratio | 2.07 | 0.01 | 0.00 | |
Price/Book | 3.4x | 2.4x | 2.6x | |
Price / LTM Sales | 10.2x | 2.0x | 3.3x | |
Upside (Analyst Target) | 43.8% | 58.5% | 45.7% | |
Fair Value Upside | Unlock | 8.0% | 6.5% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.50
(+43.84% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
0.06 / 0.06
Revenue / Forecast
29.25M / 31.45M
People Also Watch
FAQ
What Is the Arcticzymes Tech (AZT) Stock Price Today?
The Arcticzymes Tech stock price today is 21.90
What Stock Exchange Does Arcticzymes Tech Trade On?
Arcticzymes Tech is listed and trades on the Oslo Stock Exchange.
What Is the Stock Symbol for Arcticzymes Tech?
The stock symbol for Arcticzymes Tech is "AZT."
What Is the Arcticzymes Tech Market Cap?
As of today, Arcticzymes Tech market cap is 1.12B.
What Is Arcticzymes Tech's Earnings Per Share (TTM)?
The Arcticzymes Tech EPS (TTM) is 0.15.
When Is the Next Arcticzymes Tech Earnings Date?
Arcticzymes Tech will release its next earnings report on Feb 12, 2026.
From a Technical Analysis Perspective, Is AZT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Arcticzymes Tech Stock Split?
Arcticzymes Tech has split 1 times.
How Many Employees Does Arcticzymes Tech Have?
Arcticzymes Tech has 53 employees.
What is the current trading status of Arcticzymes Tech (AZT)?
As of Feb 07, 2026, Arcticzymes Tech (AZT) is trading at a price of 21.90, with a previous close of 21.10. The stock has fluctuated within a day range of 20.60 to 21.90, while its 52-week range spans from 13.60 to 31.40.
What Is Arcticzymes Tech (AZT) Price Target According to Analysts?
The average 12-month price target for Arcticzymes Tech is NOK31.50, with a high estimate of NOK32 and a low estimate of NOK31. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +43.84% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.